Does Oscar Health Cover Eliquis? A Complete Coverage Guide

What Is Eliquis and Why Anticoagulant Coverage Matters

Eliquis is the brand name for apixaban, a direct oral anticoagulant (DOAC) that works by selectively inhibiting Factor Xa. The FDA first approved apixaban in December 2012 for reducing stroke risk in non-valvular atrial fibrillation, then expanded that label to cover DVT and PE treatment and prophylaxis after hip or knee replacement surgery [1]. Millions of Americans depend on it daily.

Clinical Background on Apixaban

The ARISTOTLE trial (N=18,201) demonstrated that apixaban 5 mg twice daily reduced the rate of stroke or systemic embolism by 21% compared with warfarin (1.27% vs. 1.60% per year, P<0.001), while also cutting major bleeding by 31% [2]. The AMPLIFY trial (N=5,395) showed apixaban was non-inferior to conventional enoxaparin/warfarin therapy for acute VTE treatment and produced 69% less major bleeding (0.6% vs. 1.8%, P<0.001) [3].

These outcomes explain why guidelines matter here. The 2023 American Heart Association/American College of Cardiology/American College of Clinical Pharmacy guideline for atrial fibrillation lists DOACs, including apixaban, as the preferred anticoagulant over vitamin K antagonists for most patients with non-valvular AFib [4]. When insurance creates access barriers to a guideline-preferred drug, the clinical stakes are real.

Why Formulary Tier Placement Affects You Directly

Formulary tiers determine what you pay. A Tier 1 generic might cost $5 per fill. A Tier 4 preferred brand like Eliquis can cost $100, $230 per month at the pharmacy counter before you hit your deductible. Oscar Health operates on a tiered formulary model across its ACA marketplace, employer, and Medicare Advantage plans, and the tier assigned to apixaban differs by plan type and plan year [5].

Oscar Health's Formulary Structure: How Tiers Work

Oscar uses a multi-tier formulary that assigns every covered drug to a cost-sharing category. Understanding the tier system is the first step before calling your pharmacy.

Typical Tier Definitions in Oscar Plans

• Tier 1: Low-cost generics, usually $0, $10 per fill.
• Tier 2: Preferred generics and some brand drugs, usually $15, $40.
• Tier 3: Non-preferred generics and preferred brands, usually $45, $100.
• Tier 4: Non-preferred brands and some specialty drugs, usually $100, $230+.
• Tier 5 (some plans): Specialty drugs, may require specialty pharmacy and step therapy.

Apixaban generics, which became available in May 2023 after Pfizer and Bristol Myers Squibb's exclusivity period ended, are now appearing on Tier 1 or Tier 2 of many Oscar formularies [6]. Brand Eliquis typically sits on Tier 3 or Tier 4. If your prescriber writes "brand medically necessary," Oscar may still require a separate prior authorization to override a generic substitution.

How to Find Your Exact Tier

1. Log in to your Oscar member account at hioscar.com.
2. Click "Benefits" then "Drug Coverage" or "Formulary."
3. Search "apixaban" (generic) and "Eliquis" (brand) separately.
4. Note the tier, quantity limit, and any step therapy or prior authorization flags.

If you are shopping for a new Oscar plan during open enrollment, the federal Health Insurance Marketplace at healthcare.gov also hosts formulary files for every ACA-qualified plan, updated annually by November 1 [5].

Prior Authorization for Eliquis on Oscar Health Plans

Prior authorization (PA) is Oscar's process for verifying that a drug is medically appropriate before the plan pays for it. Most Oscar plans require PA for brand Eliquis.

What Prior Authorization Typically Requires

Oscar's PA criteria for apixaban generally align with FDA-labeled indications [1]. Your prescriber's office will need to submit:

• A confirmed diagnosis code (e.g., I48.0 for paroxysmal AFib, I82.401 for DVT).
• Documentation of CHA2DS2-VASc score for AFib patients (score of 2 or higher in men, 3 or higher in women is the threshold at which most guidelines recommend anticoagulation) [4].
• Lab values showing renal and hepatic function, since apixaban dose reduction criteria depend on serum creatinine, age, and body weight.
• In some plans, a step-therapy attestation confirming whether warfarin was tried or is contraindicated.

Under the ACA, Oscar must notify you of a PA determination within 72 hours for urgent requests and 15 calendar days for standard requests [7]. If PA is denied, you have the right to an internal appeal and, if that fails, an external independent review.

Step Therapy: The Warfarin-First Requirement

Some Oscar plans include a step therapy protocol requiring a 30-day documented trial of warfarin before approving apixaban. Step therapy for anticoagulants is clinically controversial. The ACC/AHA AFib guideline explicitly states that "DOACs are recommended over warfarin in DOAC-eligible patients with AF" [4], which your prescriber can cite as the basis for a step-therapy exception.

Step therapy exceptions are federally protected under the Restoring the Patient's Voice Act concept adopted in ACA plans and under state laws in over 30 states. Your physician can request an exception by submitting a clinical rationale letter stating that warfarin poses a safety risk or is clinically inferior for your specific case.

How Much Does Eliquis Cost on Oscar Health?

Cost depends on three variables: your plan's tier assignment, whether you have met your deductible, and whether you use any assistance programs.

Pre-Deductible vs. Post-Deductible Costs

Before you meet your annual deductible, Oscar typically charges you the negotiated contract price for Eliquis, which ranges from roughly $180 to $550 for a 30-day supply depending on your plan's pharmacy benefit manager contract. After you meet your deductible, you pay only your tier-based copay or coinsurance.

The average annual deductible for ACA individual plans in 2024 was $1,992, according to KFF [8]. If you take Eliquis year-round, you may exhaust your deductible in the first two to three months of the year, after which your copay drops significantly.

Out-of-Pocket Maximum Protection

The ACA caps individual out-of-pocket costs at $9,450 in 2024 [5]. Once you reach that limit, Oscar covers 100% of covered drug costs, including Eliquis, for the remainder of the plan year. For patients who take multiple expensive medications, tracking your running out-of-pocket total is practical financial planning.

How to Lower Your Eliquis Cost With Oscar Health

Even when Oscar covers Eliquis, the copay can still strain a monthly budget. Several programs can close that gap.

The Bristol Myers Squibb / Pfizer Eliquis Copay Card

Patients with commercial insurance (not Medicare or Medicaid) may qualify for the Eliquis 360 Support copay card, which can reduce monthly costs to as low as $10 for a 30-day supply or $20 for a 90-day supply. The manufacturer program covers up to $6,400 per year in out-of-pocket costs. Enrollment is available at eliquis.bmscustomerconnect.com or by calling 855-ELIQUIS. Oscar Health is a commercial insurer, so most Oscar members qualify unless they are enrolled in Oscar's Medicare Advantage product [9].

Switching to Generic Apixaban

Generic apixaban, manufactured by companies including Mylan (Viatris) and Teva, became commercially available in the U.S. In May 2023 following litigation settlements with Bristol Myers Squibb and Pfizer [6]. The FDA confirms therapeutic equivalence of approved generic apixaban products to brand Eliquis, meaning the same active ingredient, dose, route, and bioavailability [10]. On Oscar's Tier 1 or Tier 2, generic apixaban may cost as little as $10, $40 per month, and the copay card programs above do not apply to generics, so switching could actually be cheaper.

Ask your pharmacist to run both the brand and generic price before filling. Some pharmacy benefit managers still route generic apixaban through a separate formulary tier than brand Eliquis.

Patient Assistance Programs

If you are uninsured, underinsured, or on Medicare, Bristol Myers Squibb's Patient Assistance Foundation may provide Eliquis at no cost. Income eligibility thresholds apply. The NeedyMeds database and RxAssist.org are two free directories for locating PAPs for apixaban [11].

What to Do If Oscar Denies Coverage for Eliquis

A denial is not a final answer. Oscar's internal appeal and external review process gives you multiple recourse pathways.

Step 1: Request the Denial Explanation

Oscar must provide a written Explanation of Benefits (EOB) or denial letter specifying the reason. Common denial reasons include: drug not on formulary, PA criteria not met, step therapy not completed, quantity limit exceeded, or non-covered indication. Each reason has a different appeal strategy.

Step 2: File an Internal Appeal

You or your prescriber can file a formal internal appeal with Oscar within 180 days of the denial. Your prescriber should submit a letter of medical necessity citing:

• The specific diagnosis and its ICD-10 code.
• Why warfarin or other alternatives are clinically inferior or contraindicated for you.
• Supporting guideline language. The 2023 ACC/AHA AFib guideline gives apixaban a Class I recommendation (the highest level) for most AFib patients [4].
• Relevant trial data such as ARISTOTLE [2] or AMPLIFY [3] demonstrating the superiority of apixaban over warfarin in bleeding outcomes.

Oscar must respond within 30 days for standard medical appeals and within 72 hours for urgent/expedited appeals [7].

Step 3: Request an External Independent Review

If Oscar upholds the denial internally, you have the right to an Independent Medical Review (IMR) by a third-party organization. Under ACA regulations, Oscar must abide by the IMR organization's decision [7]. IMR overturn rates for prescription drug denials nationally run approximately 39 to 42%, according to CMS data on external reviews [12].

Step 4: File a State Insurance Commissioner Complaint

Every state has an insurance commissioner's office that accepts consumer complaints against health insurers. If you believe Oscar violated coverage rules or acted in bad faith, a formal complaint can trigger a regulatory audit of your denial. The National Association of Insurance Commissioners (NAIC) maintains a directory of state offices at naic.org.

Eliquis Dosing Basics: What Your Prescriber Will Document

Understanding the approved doses helps you verify that your prescription matches what Oscar's PA criteria expect.

FDA-Approved Dosing Regimens

For non-valvular atrial fibrillation, the standard dose is 5 mg orally twice daily. Patients meeting at least two of three criteria (age 80 or older, body weight 60 kg or less, or serum creatinine 1.5 mg/dL or higher) are dose-reduced to 2.5 mg twice daily [1]. For acute DVT/PE treatment, the regimen starts at 10 mg twice daily for 7 days, then drops to 5 mg twice daily [1]. Post-surgical prophylaxis uses 2.5 mg twice daily for 12 days after knee replacement or 35 days after hip replacement.

Oscar's PA forms typically request the prescribed dose and indication. Submitting the correct dose for the correct indication accelerates approval.

Drug Interactions That May Appear in PA Documentation

Apixaban is a P-glycoprotein and CYP3A4 substrate. Co-administration with strong dual inhibitors of both pathways (e.g., ketoconazole, itraconazole, ritonavir) increases apixaban exposure and may require dose reduction. Strong dual inducers (e.g., rifampin, carbamazepine, phenytoin) reduce apixaban levels substantially. The FDA label recommends avoiding apixaban in patients taking strong dual inducers [1]. If a patient is on one of these interacting drugs, that clinical detail may be relevant to the PA submission and may affect Oscar's coverage decision.

Oscar Health Medicare Advantage and Eliquis

If you are enrolled in an Oscar Medicare Advantage plan rather than an ACA marketplace plan, the coverage rules differ in two important ways.

Part D Formulary Rules for Eliquis

Medicare Part D plans, including those administered through Oscar Medicare Advantage, are required by CMS to cover at least two drugs in every therapeutic category, including anticoagulants [13]. Apixaban is universally covered on Medicare Part D formularies, though tier placement and cost-sharing vary. In 2024, Eliquis is covered under Medicare Part D but may sit on a non-preferred brand tier with a standard copay between $47 and $100 per month in the initial coverage phase.

The Medicare Donut Hole and Catastrophic Coverage

In 2024, Medicare Part D beneficiaries enter the coverage gap (donut hole) after total drug costs reach $5,030 and pay 25% of drug costs until reaching the catastrophic threshold of $8,000 in true out-of-pocket spending [13]. Starting in 2025, the Inflation Reduction Act caps Medicare Part D out-of-pocket costs at $2,000 annually, which may significantly reduce apixaban costs for Oscar Medicare Advantage members [14].

The Bristol Myers Squibb copay card does not apply to Medicare beneficiaries because federal anti-kickback regulations prohibit manufacturer copay assistance for government-insured patients [9].

Comparing Eliquis to Other DOACs: Does Oscar Cover Alternatives?

If Eliquis coverage is denied, understanding how Oscar covers other anticoagulants helps you and your prescriber choose the next step.

Rivaroxaban (Xarelto)

Rivaroxaban, marketed as Xarelto by Janssen, is FDA-approved for similar indications [15]. The ROCKET-AF trial (N=14,264) showed rivaroxaban was non-inferior to warfarin for stroke prevention in AFib, with no significant difference in major bleeding [16]. Generic rivaroxaban is not yet widely available in the U.S., so it may carry a similar tier placement as brand Eliquis on Oscar's formulary.

Dabigatran (Pradaxa)

Dabigatran, the first approved DOAC in the U.S. (2010), works via direct thrombin inhibition rather than Factor Xa inhibition. The RE-LY trial (N=18,113) showed dabigatran 150 mg twice daily reduced stroke risk by 35% compared with warfarin [17]. Oscar formularies may place dabigatran on a different tier than apixaban, and the twice-daily dosing without food requirements may suit some patients better.

Warfarin as a Step-Therapy Alternative

Warfarin remains on Tier 1 of virtually every formulary, often at $4, $10 per month. The clinical trade-off is the need for regular INR monitoring, a narrow therapeutic index, and significantly more drug-food interactions. The ARISTOTLE trial showed apixaban produced 31% less major bleeding than warfarin, a difference your prescriber can cite when arguing against a warfarin step-therapy requirement [2].

Practical Checklist: Getting Eliquis Covered by Oscar Health

Use this checklist before your pharmacy visit or after a denial.

1. Log in to hioscar.com and look up "apixaban" and "Eliquis" in the drug coverage tool. Note the tier and any PA flags.
2. Ask your prescriber's office to submit the PA request before you pick up your first fill. Many PA denials happen because the first fill is attempted without authorization.
3. Confirm your diagnosis code matches an FDA-approved indication. A code for "atrial flutter" (I48.4) without AFib documentation could trigger a denial.
4. Ask about generic apixaban. If your Oscar plan places it on Tier 1 or 2, the generic may cost less than the brand even with the manufacturer copay card.
5. Enroll in the BMS/Pfizer copay card program if you have commercial Oscar coverage (not Medicare Advantage). Do this before your first fill so the card activates at the pharmacy counter.
6. Keep a copy of every PA submission date-stamped. If Oscar misses its response deadline, that is a separate regulatory violation you can report.
7. If denied, respond within 30 days with a letter of medical necessity from your prescriber citing ARISTOTLE [2], AMPLIFY [3], and the 2023 ACC/AHA guideline [4].